Olin biology: adsorbed tetanus vaccine obtained drug re registration approval
Financial Associated Press, September 23 (Xinhua), Olin biology announced that the adsorbed tetanus vaccine declared by the company has obtained the drug re registration approval notice.
This text is a result of machine translation.
Related companies：
In-depth
Briefing Jun 23, 2022 02:14 PM
· Financials
Minsheng Bank newly established the post of chief economist Wen bin
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing May 18, 2022 09:28 AM
· Technology
97 shares were financed to buy more than 100 million yuan, and BYD was the first to buy 1.113 billion yuan
Briefing Mar 12, 2022 06:09 AM
· Financials
The financial data in February was less than expected, and experts said it was necessary to reduce the reserve requirement and interest rate
Briefing Aug 25, 2021 07:01 AM
· Financials
More than 60% of private equity are optimistic about investment opportunities in popular racetracks
See more
Read next
Insight
In-depth
Automotive · Analysis
The Influence of Leadership Change in Latin American Countries on Chinese Enterprises(One)
Sep 04, 2024 09:50 PM
Insight
In-depth
Insight
In-depth
Automotive · Analysis
Chinese Companies Going Overseas: Blindly Copying Foreign Companies is “Seeking Death”
Sep 04, 2024 08:37 PM